Metagenomi, Inc. financial data

Symbol
MGX on Nasdaq
Location
5959 Horton Street, 7 Th Floor, Emeryville, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 637 % +26.1%
Debt-to-equity 39.1 % -48.9%
Return On Equity -43.2 % +2.88%
Return On Assets -31.1 % -60.1%
Operating Margin -298 % -85.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 0 shares -100%
Common Stock, Shares, Outstanding 37.5M shares +0.3%
Entity Public Float 127M USD
Common Stock, Value, Issued 4K USD 0%
Weighted Average Number of Shares Outstanding, Basic 37.3M shares +1.59%
Weighted Average Number of Shares Outstanding, Diluted 37.3M shares +1.59%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 30.9M USD -43.9%
Research and Development Expense 96.1M USD -13.2%
General and Administrative Expense 27.1M USD -17.4%
Operating Income (Loss) -92.3M USD -4.29%
Nonoperating Income (Expense) 2.23M USD -82.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -90M USD -19.2%
Income Tax Expense (Benefit) -1.3M USD -146%
Net Income (Loss) Attributable to Parent -88.7M USD -20%
Earnings Per Share, Basic -2 USD/shares +72.1%
Earnings Per Share, Diluted -2 USD/shares +72.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 32.8M USD +30.5%
Cash, Cash Equivalents, and Short-term Investments 184M USD -33%
Accounts Receivable, after Allowance for Credit Loss, Current 900K USD
Assets, Current 190M USD -32.8%
Property, Plant and Equipment, Net 13.9M USD -29.5%
Operating Lease, Right-of-Use Asset 36M USD -10.4%
Other Assets, Noncurrent 809K USD +153%
Assets 248M USD -30.8%
Accounts Payable, Current 1.22M USD -60.8%
Contract with Customer, Liability, Current 12.9M USD -55.6%
Liabilities, Current 29.6M USD -35.3%
Contract with Customer, Liability, Noncurrent 1.9M USD -84.7%
Operating Lease, Liability, Noncurrent 36.1M USD -12.8%
Other Liabilities, Noncurrent 1.92M USD -37.6%
Liabilities 69.5M USD -32.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax 371K USD -77.4%
Retained Earnings (Accumulated Deficit) -288M USD -44.5%
Stockholders' Equity Attributable to Parent 178M USD -30.2%
Liabilities and Equity 248M USD -30.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -22.8M USD +23.5%
Net Cash Provided by (Used in) Financing Activities -77K USD -100%
Net Cash Provided by (Used in) Investing Activities 24.7M USD
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 37.5M shares +0.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.81M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 38M USD +25.2%
Deferred Tax Assets, Valuation Allowance 66.6M USD +39.3%
Operating Lease, Liability 45.8M USD
Depreciation 1.36M USD +6.68%
Payments to Acquire Property, Plant, and Equipment 288K USD -68.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -90M USD -25.1%
Lessee, Operating Lease, Liability, to be Paid 63.4M USD
Property, Plant and Equipment, Gross 29M USD +3.69%
Operating Lease, Liability, Current 5.57M USD +18.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 9.71M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 10.4M USD
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 17.6M USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 10M USD
Deferred Tax Assets, Operating Loss Carryforwards 17.9M USD +1356%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 7.55M USD +27%
Lessee, Operating Lease, Liability, to be Paid, Year Four 10.3M USD
Additional Paid in Capital 466M USD +2.8%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 12.6M USD -20.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%